The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
Open accessAbstract
SUMMARY: The entry of anti-infectives into the central nervous system (CNS) depends on the compartment studied, molecular size, electric charge, lipophilicity, plasma protein binding, affinity to active transport systems at the blood-brain/blood-cerebrospinal fluid (CSF) barrier, and host factors such as meningeal inflammation and CSF flow. Since concentrations in microdialysates and abscesses are not frequently available for humans, this review focuses on drug CSF concentrations. The ideal compound to treat CNS infections is of small molecular size, is moderately lipophilic, has a low level of plasma protein binding, has a volume of distribution of around 1 liter/kg, and is not a strong ligand of an efflux pump at the blood-brain or blood-CSF barrier. When several equally active compounds are available, a drug which comes close to these physicochemical and pharmacokinetic properties should be preferred. Several anti-infectives (e.g., isoniazid, pyrazinamide, linezolid, metronidazole, fluconazole, and some fluoroquinolones) reach a CSF-to-serum ratio of the areas under the curves close to 1.0 and, therefore, are extremely valuable for the treatment of CNS infections. In many cases, however, pharmacokinetics have to be balanced against in vitro activity. Direct injection of drugs, which do not readily penetrate into the CNS, into the ventricular or lumbar CSF is indicated when other effective therapeutic options are unavailable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
Farquhar, M. G., & Palade, G. E. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.375 · Cited by 3,635
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M. W., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,471
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Pharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
Letendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
Levin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 813
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
Shapiro, W. R., Young, D. F., & Mehta, B. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507242930402 · Cited by 681
Physiology of the cerebro-spinal fluid
(1967) · Postgraduate Medical Journal · doi:10.1136/pgmj.43.501.508 · Cited by 612
The pharmacokinetics of Norpace.
Karim, A. (1975) · PubMed · Cited by 552
INTRAVENTRICULAR GENTAMICIN THERAPY IN GRAM-NEGATIVE BACILLARY MENINGITIS OF INFANCY
REPORTOFTHESECONDNEONATALMENI (1980) · The Lancet · doi:10.1016/s0140-6736(80)91291-x · Cited by 445
Junctions in the meninges and marginal glia.
Nabeshima, S., Reese, T. S., Landis, D. M. D., & Brightman, M. W. (1975) · Journal of Comparative Neurology · doi:10.1002/cne.901640202 · Cited by 444
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Rapoport, S. I. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 444
McCracken, G. H., Mize, S. G., & Threlkeld, N. (1980) · PubMed · Cited by 393
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07109 · Cited by 392
Groll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Physiology and Pathophysiology of the Cerebrospinal Fluid
Davson, H., Welch, K., & Segal, M. B. (1987) · Medical Entomology and Zoology · Cited by 352
Recent research into the nature of cerebrospinal fluid formation and absorption
McComb, J. G. (1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.59.3.0369 · Cited by 336
Efflux of radiolabeled polyethylene glycols and albumin from rat brain
Cserr, H. F., Cooper, D. N., Suri, P. K., & Patlak, C. S. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.240.4.f319 · Cited by 323
Cerebrospinal fluid production is reduced in healthy aging
May, C., Kaye, J. A., Atack, J. R., Schapiro, M. B., Friedland, R. P., & Rapoport, S. I. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.500 · Cited by 315
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Rodvold, K. A., Gotfried, M. H., Cwik, M., Korth-Bradley, J. M., Dukart, G., & Ellis-Grosse, E. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl403 · Cited by 304
Pihet, M., Carrere, J., Cimon, B., Chabasse, D., Delhaes, L., Symoens, F., Bouchara, J.-P., Pihet, M., Carrere, J., Cimon, B., et al. (2009) · Medical Mycology · doi:10.1080/13693780802609604 · Cited by 303
Leenders, A. C. A. P., Reiss, P., Portegies, P., Clezy, K., Hop, W. C. J., Hoy, J., Borleffs, J. C. C., Allworth, T., Kauffmann, R. H., Jones, P., et al. (1997) · AIDS · doi:10.1097/00002030-199712000-00010 · Cited by 289
Dacey, R. G., & Sande, M. A. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.4.437 · Cited by 287
Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis
Kaiser, A. B., & McGee, Z. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512112932401 · Cited by 263
Lutsar, I., Roffey, S., & Troke, P. (2003) · Clinical Infectious Diseases · doi:10.1086/377131 · Cited by 262
de Lange, E. C. M., & Danhof, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00001 · Cited by 244
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
Lutsar, I., McCracken, Jr., & Friedland, I. R. (1998) · Clinical Infectious Diseases · doi:10.1086/515003 · Cited by 242
Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging
Nilsson, C., Stahlberg, F., Thomsen, C., Henriksen, O., Herning, M., & Owman, C. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.1.r20 · Cited by 233
Andes, D., Marchillo, K., Stamstad, T., & Conklin, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3165-3169.2003 · Cited by 231
Extracellular space of brain as determined by diffusion of inulin from the ventricular system
Rall, D. P., Oppelt, W. W., & Patlak, C. S. (1962) · Life Sciences · doi:10.1016/0024-3205(62)90104-2 · Cited by 219
Methods for quantifying the transport of drugs across brain barrier systems
Fenstermacher, J. D., Blasberg, R. G., & Patlak, C. S. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90062-0 · Cited by 214
París, M. M., Hickey, S. M., Uscher, M. I., Shelton, S., Olsen, K. D., & McCracken, G. H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1320 · Cited by 214
Scheld, W. M., Dacey, R. G., Winn, H. R., Welsh, J. E., Jane, J. A., & Sande, M. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109850 · Cited by 209
Fosfomycin: an old, new friend?
Popovic, M., Steinort, D., Pillai, S., & Joukhadar, C. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0833-2 · Cited by 197
Imipenem/cilastatin treatment of bacterial meningitis in children
WONG, V. K., WRIGHT, H. T., ROSS, L. A., MASON, W. H., INDERLIED, C. B., & KIM, K. S. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199102000-00009 · Cited by 196
Drug metabolizing enzymes in the brain and cerebral microvessels
Minn, A., Ghersi-Egea, J.-F., Perrin, R., Leininger, B., & Siest, G. (1991) · Brain Research Reviews · doi:10.1016/0165-0173(91)90020-9 · Cited by 183
Hope, W. W., Mickiene, D., Petraitis, V., Petraitiene, R., Kelaher, A. M., Hughes, J. E., Cotton, M. P., Bacher, J., Keirns, J. J., Buell, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524063 · Cited by 183
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model
Andes, D., Stamsted, T., & Conklin, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.922-926.2001 · Cited by 180
Liu, X., Van Natta, K., Yeo, H., Vilenski, O., Weller, P. E., Worboys, P. D., & Monshouwer, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024125 · Cited by 179
BARRIER MECHANISMS IN THE BRAIN, II. IMMATURE BRAIN
Saunders, N., Habgood, M., & Dziegielewska, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02987.x · Cited by 173
CSF hydrodynamic studies in man. 1. Method of constant pressure CSF infusion.
Ekstedt, J. (1977) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.40.2.105 · Cited by 171
Die äussere und innere Sekretion des gesunden Organismus im Lichte der "vitalen Färbung"
Goldmann, E. E. (1909) · University of Michigan Library Repository · Cited by 170
Protein Analysis in Cerebrospinal Fluid
Blennow, K., Fredman, P., Wallin, A., Gottfries, C.-G., Karlsson, I., Långstrom, G., Skoog, I., Svennerholm, L., & Wikkelsö, C. (1993) · European Neurology · doi:10.1159/000116919 · Cited by 169
De Sarro, A., Ammendola, D., Zappala, M., Grasso, S., & De Sarro, G. B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.232 · Cited by 167
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis
Tucker, R. M., Williams, P. L., Arathoon, E. G., Levine, B. E., Hartstein, A. I., Hanson, L. H., & Stevens, D. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.3.369 · Cited by 159
Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis
Karlsson, M., Hammers-Berggren, S., Lindquist, L., Stiernstedt, G., & Svenungsson, B. (1994) · Neurology · doi:10.1212/wnl.44.7.1203 · Cited by 158
Pfausler, B., Spiss, H., Beer, R., Kampfl, A., Engelhardt, K. W., Schober, M., & Schmutzhard, E. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.5.1040 · Cited by 155
Albanèse, J., Léone, M., Bruguerolle, B., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1356-1358.2000 · Cited by 155
Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
Debruyne, D. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733010-00005 · Cited by 153
Me, J.-M., Pichardo-Guerrero, C., Márquez-Rivas, J., Martín-Lozano, D., Prados, T., & Pachón, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-0680-2 · Cited by 145
Tozzi, V., Balestra, P., Salvatori, M. F., Vlassi, C., Liuzzi, G., Giancola, M. L., Giulianelli, M., Narciso, P., & Antinori, A. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181af83d6 · Cited by 144
Nagata, Y., Kusuhara, H., Endou, H., & Sugiyama, Y. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.982 · Cited by 144
Randomized Comparison of Ceftriaxone and Cefotaxime in Lyme Neuroborreliosis
Pfister, H.-W., Preac‐Mursic, V., Wilske, B., Schielke, E., Sörgel, F., & Einhäupl, K. M. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.2.311 · Cited by 143
Ricard, J.-D., Wolff, M., Lachérade, J.-C., Mourvillier, B., Hidri, N., Barnaud, G., Chevrel, G., Bouadma, L., & Dreyfuss, D. (2006) · Clinical Infectious Diseases · doi:10.1086/510390 · Cited by 142
Cerebrospinal Fluid Drug Concentrations and the Treatment of Tuberculous Meningitis
Ellard, G. A., Humphries, M. J., & Allen, B. W. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.3.650 · Cited by 141
Pfausler, B., Spiss, H., Dittrich, P., Zeitlinger, M., Schmutzhard, E., & Joukhadar, C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh158 · Cited by 140
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges
Nau, R., Prange, H. W., Muth, P., Mahr, G., Menck, S., Kolenda, H., & Sörgel, F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1518 · Cited by 138
Self-citationBree, J. B., Boer, A. G. D., Danhof, M., Ginsel, L. A., & Breimer, D. D. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13283-7 · Cited by 136
Yim, C. W., Flynn, N. M., & Fitzgerald, F. T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.347 · Cited by 133
Sáez‐Llorens, X., Castaño, E., García, R., Báez-Ulloa, C., Pérez, M., Tejeira, F., & McCracken, G. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.937 · Cited by 130
CNS pharmacokinetics of antifungal agents
Kethireddy, S., & Andes, D. R. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.4.573 · Cited by 128
Cefotaxime vs Penicillin G for Acute Neurologic Manifestations in Lyme Borreliosis
Pfister, H.-W. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520470044025 · Cited by 121
Role of P-Glycoprotein Inhibition for Drug Interactions
Eberl, S., Renner, B., Neubert, A. C., Reisig, M., Bachmakov, I., König, J., Dörje, F., Mürdter, T. E., Ackermann, A., Dormann, H., et al. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746120-00004 · Cited by 120
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00001 · Cited by 118
Pardridge, W. M., Sakiyama, R., & Fierer, G. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110844 · Cited by 116
PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIBIOTICS IN MENINGITIS
Andes, D. R., & Craig, W. A. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70096-9 · Cited by 116
Acyclovir Levels in Serum and Cerebrospinal Fluid after Oral Administration of Valacyclovir
Lycke, J., Malmeström, C., & Ståhle, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2438-2441.2003 · Cited by 114
Zastre, J. A., Chan, G. N. Y., Ronaldson, P. T., Ramaswamy, M., Couraud, P. O., Romero, I. A., Weksler, B. B., Bendayan, M., & Bendayan, R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21898 · Cited by 113
Antinori, A., Perno, C. F., Giancola, M. L., Forbici, F., Ippolito, G., Hoetelmans, R. M. W., & Piscitelli, S. C. (2005) · Clinical Infectious Diseases · doi:10.1086/498310 · Cited by 112
von Wedel-Parlow, M., Wölte, P., & Galla, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06305.x · Cited by 110
Cottagnoud, P., Pfister, M., Acosta, F., Cottagnoud, M., Flatz, L., Kühn, F., Müller, H.-P., & Stucki, A. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3928-3933.2004 · Cited by 109
Flierl, M. A., Stahel, P. F., Rittirsch, D., Huber-Lang, M. S., Niederbichler, A. D., Hoesel, L. M., Touban, B. M., Morgan, S. J., Smith, W. R., Ward, P. A., et al. (2009) · Critical Care · doi:10.1186/cc7710 · Cited by 108
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye
Jaruratanasirikul, S., Hortiwakul, R., Tantisarasart, T., Phuenpathom, N., & Tussanasunthornwong, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.825 · Cited by 108
Tashima, K. T., Caliendo, A. M., Ahmad, M., Gormley, J. M., Fiske, W. D., Brennan, J. M., & Flanigan, T. (1999) · The Journal of Infectious Diseases · doi:10.1086/314945 · Cited by 108
Alffenaar, J. C., van Altena, R., Bökkerink, H. J., Luijckx, G. J., van Soolingen, D., Aarnoutse, R. E., & van der Werf, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/605576 · Cited by 105
McDowell, J. A., Chittick, G. E., Ravitch, J. R., Polk, R. E., Kerkering, T. M., & Stein, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2855 · Cited by 102
Pharmacological Studies with 5-Fluorocytosine
Block, E. R., & Bennett, J. E. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.6.476 · Cited by 101
Dotevall, L., & Hagberg, L. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.7.1078 · Cited by 97
Clinical Implications of CNS Penetration of Antiretroviral Drugs
Wynn, H. E., Brundage, R. C., & Fletcher, C. V. (2002) · CNS Drugs · doi:10.2165/00023210-200216090-00002 · Cited by 95
High-Dose Fluconazole Therapy for Cryptococcal Meningitis in Patients with AIDS
Menichetti, F., Fiorio, M., Tosti, A., Gatti, G., Pasticci, M. B., Miletich, F., Marroni, M., Bassetti, D., & Pauluzzi, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.838 · Cited by 94
Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir
Kravcik, S., Gallicano, K., Roth, V. R., Cassol, S. A., Hawley‐Foss, N., Badley, A. D., & Cameron, D. W. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199908150-00003 · Cited by 93
Blood-brain interfaces: relevance to cerebral drug metabolism
Ghersi‐Egea, J., Leininger‐Muller, B., Cecchelli, R., & Fenstermacher, J. D. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03510-9 · Cited by 92
Cerebral aspergillosis: tissue penetration is the key
Schwartz, S., & Thiel, E. (2009) · Medical Mycology · doi:10.1080/13693780802537953 · Cited by 92
Cascio, A., Conti, A., Sinardi, L., Iaria, C., Angileri, F. F., Stassi, G., David, T., Versaci, A., Iaria, M., & David, A. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.06.032 · Cited by 91
Viladrich, P. F., Cabellos, C., Pallarés, R., Tubau, F., Martínez-Lacasa, J., Liñares, J., & Gudiol, F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.218 · Cited by 88
Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
Yilmaz, A., Gisslén, M., Spudich, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006877 · Cited by 86
Dey, S., Gunda, S., & Mitra, A. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069583 · Cited by 85
Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges
Nau, R., Prange, H. W., Menck, S., Kolenda, H., Visser, K., & Seydel, J. K. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.6.719 · Cited by 85
Self-citationMitjà, J., Pigrau, C., Ruíz-Camps, I., Vidal, X., Almirante, B., Planes, A. M. C., Molina, I., Rodríguez-Pardo, D., & Pahissa, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp180 · Cited by 85
Plasma and CSF Levels of Albendazole and Praziquantel in Patients with Neurocysticercosis
Jung, H., Hurtado, M., Sánchez, M., Medina, M. T., & Sotelo, J. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199012000-00008 · Cited by 82
McLeod, R. L., Mack, D. G., Foss, R. R., Boyer, K. M., Withers, S., Levin, S., & Hubbell, J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1040 · Cited by 82
Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges
Dagan, R., Velghe, L., Rodda, J., & Klugman, K. P. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.1.175 · Cited by 81
Cerebrospinal Fluid Concentrations of Rifampin in Meningeal Tuberculosis
D'Oliveira, J. J. G. (1972) · American Review of Respiratory Disease · doi:10.1164/arrd.1972.106.3.432 · Cited by 80
Protein Analysis in Cerebrospinal Fluid
Blennow, K., Fredman, P., Wallin, A., Gottfries, C., Skoog, I. G., Wikkelsø, C., & Svennerholm, L. T. (2008) · European Neurology · doi:10.1159/000116920 · Cited by 79
Shah, M. V., Audus, K. L., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015913817221 · Cited by 78
Penetration of the blood brain barrier by metronidazole and tinidazole
Jokipii, A. M. M., Myllylä, V. V., Hokkanen, E., & Jokipii, L. (1977) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/3.3.239 · Cited by 77
Injury of the Blood Brain Barrier and Up-Regulation of ICAM-1 in Polymicrobial Sepsis
Hofer, S., Bopp, C., Hoerner, C., Plaschke, K., Faden, R. M., Martin, E., Bardenheuer, H. J., & Weigand, M. A. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.07.021 · Cited by 76
Karlsson, M., Hammers, S., Nilsson-Ehle, I., Malmborg, A. S., & Wretlind, B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1104 · Cited by 76
Posaconazole concentrations in the central nervous system
Rüping, M. J. G. T., Albermann, N., Ebinger, F., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn409 · Cited by 75
Dudley, M. N., Levitz, R. E., Quintiliani, R., Hickingbotham, J. M., & Nightingale, C. H. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.6.811 · Cited by 72
Mindermann, T., Zimmerli, W., & Gratzl, O. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2626 · Cited by 71
Protein filtration and secretion at human body fluid barriers
Felgenhauer, K. (1980) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00589509 · Cited by 71
Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis
Wolff, M., Boutron, L., Singlas, E., Clair, B., Decazes, J. M., & Regnier, B. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.6.899 · Cited by 70
Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid
Lutsar, I., & Friedland, I. R. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039050-00003 · Cited by 70
Alexander, S. C. (1972) · Anesthesiology · doi:10.1097/00000542-197202000-00033 · Cited by 68
Andersson, L. (2001) · Journal of NeuroVirology · doi:10.1080/135502801753248123 · Cited by 66
Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress
Spector, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06451.x · Cited by 65
Kaojarern, S., Supmonchai, K., Phuapradit, P., Mokkhavesa, C., & Krittiyanunt, S. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.2 · Cited by 63
Sjövall, J., Bergdahl, S., Movin, G., Ogenstad, S., & Saarimäki, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.7.1023 · Cited by 62
Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis
Hengge, U. R., Brockmeyer, N. H., Malessa, R., Ravens, U., & Goos, M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1010 · Cited by 61
The morphological correlates of primate cerebrospinal fluid absorption
Levine, J. E., Povlishock, J. T., & Becker, D. P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91225-2 · Cited by 60
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916050-00001 · Cited by 60
Successful Treatment of Methicillin‐ResistantStaphylococcus aureusMeningitis with Daptomycin
Lee, D. H., Palermo, B., & Chowdhury, M. (2008) · Clinical Infectious Diseases · doi:10.1086/590257 · Cited by 60
Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir
Kravcik, S., Gallicano, K., Roth, V. R., Cassol, S. A., Hawley‐Foss, N., Badley, A. D., & Cameron, D. W. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908150-00003 · Cited by 60
Mursch, K., Trnovec, S., Ratz, H., Hammer, D., Horré, R., Klinghammer, A., de Hoog, S., & Behnke‐Mursch, J. (2005) · Child s Nervous System · doi:10.1007/s00381-005-1151-3 · Cited by 58
Quagliarello, V., Ma, A., Stukenbrok, H., & Palade, G. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.3.657 · Cited by 57
High‐dose therapy with fluconazole ≥ 800 mg day ‐1
Duswald, K. H., Penk, A., & Pittrow, L. B. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00231.x · Cited by 53
Karpati, G., Carpenter, S., Clarke, J. T. R., & Wolfe, L. S. (1971) · PubMed · Cited by 53
Nau, R., Sörgel, F., & Prange, H. W. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90052-3 · Cited by 51
Self-citationOkugawa, S., Ota, Y., Tatsuno, K., Tsukada, K., Kishino, S., & Koike, K. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600951333 · Cited by 48
Elter, T., Sieniawski, M. K., Goßmann, A., Wickenhauser, C., Schröder, U., Seifert, H., Kuchta, J., Burhenne, J., Riedel, K., Fätkenheuer, G., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.04.006 · Cited by 48
Yilmaz, A., Ståhle, L., Hagberg, L., et al. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410025320 · Cited by 45
Takayanagui, O. M., Bonato, P. S., Dreossi, S. A. C., & Lanchote, V. L. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01634.x · Cited by 43
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies
Nau, R., Prange, H. W., Kinzig, M., Frank, A., Dressel, A., Scholz, P., Kolenda, H., & Sörgel, F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.763 · Cited by 43
Self-citationModeling the Enhanced Uptake of Zidovudine (AZT) into Cerebrospinal Fluid. 1. Effect of Probenecid
Sawchuk, R. J., & Hedaya, M. A. (1990) · Pharmaceutical Research · doi:10.1023/a:1015854902915 · Cited by 41
Ceftriaxone pharmacokinetics in the central nervous system.
Spector, R. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38906-8 · Cited by 41
Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man
Nau, R., Zysk, G., Thiel, A., & Prange, H. W. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315520 · Cited by 40
Self-citationKinetics of Intraventricular Vancomycin in Infections of Cerebrospinal Fluid Shunts
Reesor, C., Chow, A. W., Kurelshi, A., & Jewesson, P. J. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.5.1142 · Cited by 39
van der Valk, P. G., Kraai, E., Vader, P. C. V. V., Haaxma-Reiche, H., & Snijder, J. A. M. (1988) · Sexually Transmitted Infections · doi:10.1136/sti.64.4.223 · Cited by 38
Foulds, G. H., Mcbride, T. J., Knirsch, A. K., Rodriguez, W. J., & Khan, W. N. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.11.1703 · Cited by 37
Bakken, J., Bruun, J. N., Gaustad, P., & Tasker, T. C. G. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.481 · Cited by 32
Imai, T., Yamamoto, T., Tanaka, S., Kashiwagi, M., Chiba, S., Matsumoto, H., & Uede, T. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.829 · Cited by 28
Amoxicillin Entry into Human Cerebrospinal Fluid: Comparison with Ampicillin
Clumeck, N., Thys, J. P., Vanhoof, R., et al. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.4.531 · Cited by 27
Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole
Wang, E. E. L., & Prober, C. G. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/11.4.385 · Cited by 26
Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates
Serabe, B. M., Murry, D. J., Dauser, R., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050916 · Cited by 24
Manosuthi, W., Chetchotisakd, P., Nolen, T. L., Wallace, D., D, S. S. M., Anekthananon, T., Supparatpinyo, K., Pappas, P. G., Larsen, R., Filler, S., et al. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00778.x · Cited by 24
Anderson, B. D., Morgan, M. E., & Singhal, D. (1995) · Pharmaceutical Research · doi:10.1023/a:1016299507382 · Cited by 20
Kuroda, M., Kusuhara, H., Endou, H., & Sugiyama, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085027 · Cited by 18
Denes, É., Pichon, N., Debette‐Gratien, M., Bouteille, B., & Gaulier, J. (2004) · Clinical Infectious Diseases · doi:10.1086/422526 · Cited by 18
Mizen, L. W., Woodnutt, G., Kernutt, I., & Catherall, E. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.693 · Cited by 17
Pharmacokinetics of Fluconazole in the Cerebrospinal Fluid of Children with Hydrocephalus
Bafeltowska, J. J., & Buszman, E. (2005) · Chemotherapy · doi:10.1159/000088965 · Cited by 13
Open‐Access World Wide Web Resources on Sepsis
Fragoulis, K. N., Michalopoulos, A. S., & Falagas, M. E. (2008) · Clinical Infectious Diseases · doi:10.1086/590256 · Cited by 10
[Metronidazole concentration of the cerebrospinal fluid from slightly inflamed meninges].
Hg, H., Förster, D., & Muirhead, B. D. (1984) · PubMed · Cited by 8
[Diffusion of tetroxoprim and sulfadiazine in the cerebrospinal fluid of neurosurgery patients].
Albert, F., Gb, B.-F., & Vergin, H. (1984) · PubMed · Cited by 5
Cited by
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
“This discovery was later confirmed by his student Edwin Goldman in 1913 [190].”
BackgroundGut microbiota and the neuroendocrine system
Farzi, A., Fröhlich, E. E., & Holzer, P. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0600-5 · Cited by 478
Multifunctional nanoparticles for brain tumor imaging and therapy
Cheng, Y., Morshed, R. A., Auffinger, B., Tobias, A. L., & Lesniak, M. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.006 · Cited by 349
Advances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 336
Marizzoni, M., Cattaneo, A., Mirabelli, P., Festari, C., Lopizzo, N., Nicolosi, V., Mombelli, E., Mazzelli, M., Luongo, D., Naviglio, D., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200306 · Cited by 333
Metadata
- Authors
- Nau, R., Sörgel, F., & Eiffert, H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2010-10
- Volume
- 23
- Issue
- 4
- Pages
- 858-883
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2140603169
- Cited by
- 1,026
- References
- 151
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.